Overview

Effect of Vaginal Estrogen on Asymptomatic Microhematuria (AMH)

Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if vaginal estrogen use is associated with resolution of blood in the urine (microscopic hematuria) in postmenopausal women. The hypothesis is that postmenopausal women with blood in the urine (microscopic hematuria) will have higher rates of resolution of hematuria after treatment course with vaginal conjugated equine estrogen cream compared to placebo cream
Phase:
Phase 4
Details
Lead Sponsor:
Medstar Health Research Institute
Collaborator:
Pfizer
Treatments:
Estrogens
Estrogens, Conjugated (USP)